A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults
A Phase 1, Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled, Crossover, First-in-Human Study to Evaluate the Safety,
Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of PF-07853578 Administered to Healthy Adult Participants
Category & Conditions: Diabetes and Metabolic Disorders
Medicine: PF-07853578
ClinicalTrials.gov Identifier (NCT): NCT05890105
Protocol ID: C5161001
Open Plain Language Summary Result:
Click here